{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:59:58Z","timestamp":1777417198057,"version":"3.51.4"},"reference-count":59,"publisher":"SAGE Publications","issue":"7-8","license":[{"start":{"date-parts":[[1990,7,1]],"date-time":"1990-07-01T00:00:00Z","timestamp":646790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DICP"],"published-print":{"date-parts":[[1990,7]]},"abstract":"<jats:p>\n                    Zidovudine (ZDV) is the only approved antiviral for the treatment of human immunodeficiency virus infection (HIV) in the U.S. Although newer antivirals have reached Phase II testing, ZDV is now the accepted therapy against which all other agents will be compared. Zidovudine 1500 mg\/d was previously prescribed only to adult HIV-infected patients who had developed AIDS or AIDS-related complex (ARC). However, results obtained from recently completed studies indicate that a lower daily dose (500 mg) appears to be equivalent. In addition, ZDV therapy appears to be beneficial to asymptomatic HIV-infected patients with CD4\n                    <jats:sup>+<\/jats:sup>\n                    counts &gt;500\/mm\n                    <jats:sup>3<\/jats:sup>\n                    . The toxicity profile of ZDV, previously obtained from patients receiving 1500 mg\/d, consisted of either acute (e.g., fever, rash, headache) or chronic (e.g., anemia, neutropenia, myopathy) adverse effects. ZDV pharmacokinetics are variable within and between the different subpopulations of HIV-infected patients who have been studied. Bioavailability ranges from 50 to 70 percent, and values for half-life, total body clearance, and volume of distribution are 1\u20132 h, 20\u201340 mL\/min\/kg, and 1\u20132 L\/kg, respectively. Drug interactions occur primarily between ZDV and other agents that undergo hepatic glucuronidation (e.g., probenecid, sulfamethoxazole) resulting in decreased ZDV clearance. ZDV is currently measured by HPLC, radioimmunoassay and FPIA; however, the role of therapeutic monitoring is currently under investigation. Studies of ZDV therapy in neonates, pediatric patients, patients with resistant isolates of HIV, and HIV-infected patients receiving combined treatment with other reverse transcriptase inhibitors or immunomodulators are ongoing.\n                  <\/jats:p>","DOI":"10.1177\/106002809002400720","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T07:25:04Z","timestamp":1483687504000},"page":"754-760","source":"Crossref","is-referenced-by-count":4,"title":["Zidovudine Update: 1990"],"prefix":"10.1177","volume":"24","author":[{"given":"Gene D.","family":"Morse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith L.","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Santora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Rozek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1990,7,1]]},"reference":[{"key":"bibr1-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707233170401"},{"key":"bibr2-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1126\/science.2502840"},{"key":"bibr3-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004053221401"},{"key":"bibr4-106002809002400720","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-10-727"},{"key":"bibr5-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.21.8333"},{"key":"bibr6-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.20.7096"},{"key":"bibr7-106002809002400720","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9343(88)80340-1","volume":"85","author":"Blum MR","year":"1988","journal-title":"Am J Med"},{"key":"bibr8-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.49"},{"key":"bibr9-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(89)90008-9"},{"key":"bibr10-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80158-1"},{"key":"bibr11-106002809002400720","first-page":"165","volume":"45","author":"Unadkat JD","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"bibr12-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.3.394"},{"key":"bibr13-106002809002400720","volume-title":"Zidovudine (Retrovir)","author":"Product information.","year":"1990"},{"key":"bibr14-106002809002400720","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-3565(25)22658-1","volume":"245","author":"Collins JM","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr15-106002809002400720","unstructured":"Boucher FD, Prober CG, Arvin AM, A phase one study of zidovudine in infants less than three months old at risk for HIV infection. Fifth International Conference on AIDS (abstract W.B.O.2). Montreal: International Development Research Center, 1989: 203."},{"key":"bibr16-106002809002400720","first-page":"177","volume":"47","author":"Morse GD","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"bibr17-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1038\/325773a0"},{"key":"bibr18-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(88)90659-6"},{"key":"bibr19-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92903-0"},{"key":"bibr20-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410200065027"},{"key":"bibr21-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1989.01670150047004"},{"key":"bibr22-106002809002400720","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-1-41"},{"key":"bibr23-106002809002400720","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-4-280"},{"key":"bibr24-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812153192404"},{"key":"bibr25-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810063191401"},{"key":"bibr26-106002809002400720","first-page":"65","volume":"44","author":"Filut H","year":"1989","journal-title":"Geriatrics"},{"key":"bibr27-106002809002400720","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-4-279"},{"key":"bibr28-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(89)80085-4"},{"key":"bibr29-106002809002400720","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9343(88)80343-7","volume":"85","author":"Blanche S","year":"1988","journal-title":"Am J Med"},{"key":"bibr30-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(89)80086-6"},{"key":"bibr31-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91282-2"},{"key":"bibr32-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.2.321"},{"key":"bibr33-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1038\/323467a0"},{"key":"bibr34-106002809002400720","first-page":"3190","volume":"47","author":"Tavares L","year":"1987","journal-title":"Cancer Res"},{"key":"bibr35-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707233170402"},{"key":"bibr36-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240114"},{"key":"bibr37-106002809002400720","first-page":"126","volume":"47","author":"Peck C","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"bibr38-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(89)80087-8"},{"key":"bibr39-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1126\/science.2928791"},{"key":"bibr40-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1126\/science.2467383"},{"key":"bibr41-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198405000-00002"},{"key":"bibr42-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(20)30220-8"},{"key":"bibr43-106002809002400720","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-1-15"},{"key":"bibr44-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704233161705"},{"key":"bibr45-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.125"},{"key":"bibr46-106002809002400720","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-5-723"},{"key":"bibr47-106002809002400720","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-1-85"},{"key":"bibr48-106002809002400720","unstructured":"Brockmeyer NH, Mertins L, Goos M. Effect of zidovudine with phase I and II metabolism in the liver. Fifth International Conference on AIDS (abstract M.B.P. 335). Montreal: International Development Research Center, 1989: 277."},{"key":"bibr49-106002809002400720","unstructured":"Sauvageon-Marte H, Bannie F, Tabah H, Pharmacokinetics of zidovudine in AIDS patients: influence of age and hepatic disorders. Fifth International Conference on AIDS (abstract M.B.P. 323). Montreal: International Development Research Center, 1989: 275."},{"key":"bibr50-106002809002400720","unstructured":"Tartaglione T, Opheim K, Van De-Horst C, Pharmacokinetics of zidovudine in adult patients with HIV infection and hepatic disease. Fifth International Confrence on AIDS (abstract M.B.P. 332). Montreal: International Development Research Center, 1989: 277."},{"key":"bibr51-106002809002400720","unstructured":"Koda RT, Richard J, Antoniskis D, Effect of acetaminophen on the pharmacokinetics of zidovudine. Fifth International Conference on AIDS (abstract W.B.O.5). Montreal: International Development Research Center, 1989: 203."},{"key":"bibr52-106002809002400720","unstructured":"Pazin GJ, Ptachcinski RJ, Sheehan M, Ho M. Interactive pharmacokinetics of zidovudine and acetaminophen. Fifth International Conference on AIDS (abstract M.B.P. 338). Montreal: International Development Research Center, 1989: 278."},{"key":"bibr53-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90685-1"},{"key":"bibr54-106002809002400720","unstructured":"Hardy WD, Holzman RS, Avramis V, Bawdon R, Fall H, Feinberg J. Clinical and pharmacokinetic interactions of combined zidovudine and sulfadoxine-pyrimethamine prophylaxis in post-PCP AIDS patients. Fifth International Conference on AIDS 1989 (abstract T.B.P.46). Montreal: International Development Research Center, 1989: 294."},{"key":"bibr55-106002809002400720","unstructured":"Hedaya MA, Elmquist WF, Sawchuck RJ. Probenecid inhibits the metabolic and renal clearance of zidovudine in human volunteers. Fifth International Conference on AIDS (abstract W.B.O.4). Montreal: International Development Research Center, 1989: 203."},{"key":"bibr56-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.176"},{"key":"bibr57-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92087-4"},{"key":"bibr58-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80394-8"},{"key":"bibr59-106002809002400720","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.10.1801"}],"container-title":["DICP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809002400720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809002400720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:04:03Z","timestamp":1777374243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002809002400720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":59,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["10.1177\/106002809002400720"],"URL":"https:\/\/doi.org\/10.1177\/106002809002400720","relation":{},"ISSN":["1042-9611"],"issn-type":[{"value":"1042-9611","type":"print"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}